Back to Search
Start Over
Sickle Cell Disease Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Vertex Pharma, Agios Pharma, Alexion Pharma, Novartis, Afimmune, Pfizer, ADDMED
- Source :
- M2 Presswire. May 2, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-May 2, 2024-: Sickle Cell Disease Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Vertex Pharma, Agios Pharma, Alexion Pharma, Novartis, Afimmune, Pfizer, ADDMED [...]
- Subjects :
- United States. Food and Drug Administration -- Reports
Pfizer Inc. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Sickle cell anemia -- Reports -- Forecasts and trends
BCG vaccines -- Growth -- Forecasts and trends -- Reports
BCG -- Growth -- Forecasts and trends -- Reports
Epidemiology -- Forecasts and trends -- Reports
Pharmaceutical industry -- Forecasts and trends
Company growth
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.792323537